4/A//SEC Filing
MusclePharm Corp 4/A
Accession 0001144204-17-006572
CIK 0001415684operating
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 9:00 PM ET
Size
8.2 KB
Accession
0001144204-17-006572
Insider Transaction Report
Form 4/AAmended
MusclePharm CorpMSLP
Drexler Ryan Charles
Director10% Owner
Transactions
- Award
Common Stock
2016-12-08+200,000→ 283,434 total - Award
Common Stock
2017-01-01+350,000→ 633,434 total
Holdings
- 1,499,408(indirect: See Footnote)
Common Stock
Footnotes (2)
- [F1]On December 8, 2016, Mr. Drexler was granted 200,000 shares of restricted stock pursuant to the Amended and Restated Executive Employment Agreement between MusclePharm Corporation and Mr. Drexler, dated November 18, 2016 (the "Employment Agreement"). On January 1, 2017, Mr. Drexler was granted 350,000 shares of restricted stock pursuant to the Employment Agreement (the "Second Issuance"). Each grant of restricted stock vests in full upon the first anniversary of its respective grant date. The original Form 4 erroneously reported that the Second Issuance occurred on December 8, 2016. This amendment is being filed to accurately reflect that the Second Issuance occurred on January 1, 2017.
- [F2]Represents shares of common stock held by Consac LLC ("Consac"). Mr. Drexler is the Chief Executive Officer of Consac and may be deemed to be the indirect beneficial owner (as that term is defined under Rule 13d-3 of the Securities Exchange Act) of the common stock that Consac beneficially owns. Mr. Drexler has the power to direct the voting and disposition of the Issuer's common stock that Consac beneficially owns.
Documents
Issuer
MusclePharm Corp
CIK 0001415684
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001415684
Filing Metadata
- Form type
- 4/A
- Filed
- Feb 6, 7:00 PM ET
- Accepted
- Feb 7, 9:00 PM ET
- Size
- 8.2 KB